MK
Matthew Kaplan Ladenburg Thalmann Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
United Therapeutics
UTHR
$17.7B
| $391.40 | $344 |
12%
downside
| Buy |
31 Oct ‘24
10 months ago |
|
2
UroGen Pharma
URGN
$964M
| $20.84 | $53.50 |
157%
upside
| Buy |
14 Jun ‘24
1 year ago |
|
3
TG Therapeutics
TGTX
$5.16B
| $32.51 | $40 |
23%
upside
| Buy |
2 May ‘24
1 year ago |
|
4
Liquidia Corp
LQDA
$2.41B
| $28.03 | $30 |
7%
upside
| Buy |
21 Dec ‘23
1 year ago |
|
5
Ardelyx
ARDX
$1.59B
| $6.59 | $8.50 |
29%
upside
| Buy |
3 Aug ‘23
2 years ago |
|
|
AVDL
6
Avadel Pharmaceuticals
AVDL
$1.5B
| $15.45 | $16 |
4%
upside
| Buy |
2 May ‘23
2 years ago |
|
7
Kiora Pharmaceuticals
KPRX
$9.2M
| $2.68 | $1,071 |
39,863%
upside
| Buy |
8 Feb ‘23
2 years ago |
|
8
Beyond Air
XAIR
$19.1M
| $3.65 | $460 |
12,503%
upside
| Buy |
29 Jun ‘22
3 years ago |
|
|
OKUR
9
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$35.2M
| $2.60 | $450 |
17,208%
upside
| Buy |
22 Nov ‘21
3 years ago |
|
10
Lipocine
LPCN
$15.8M
| $2.91 | $51 |
1,653%
upside
| Buy |
10 Dec ‘20
4 years ago |
|
11
Cogent Biosciences
COGT
$1.78B
| $12.72 | $16 |
26%
upside
| Buy |
14 Oct ‘20
4 years ago |
|
12
Protara Therapeutics
TARA
$118M
| $3.07 | $45 |
1,366%
upside
| Buy |
22 Jan ‘20
5 years ago |
|